337
Views
15
CrossRef citations to date
0
Altmetric
Applied Mycology

DNA cleavage of the fungal pathogen and production of antifungal compounds are the possible mechanisms of action of biocontrol agent Penicillium italicum against Macrophomina phaseolina

ORCID Icon & ORCID Icon
Pages 24-34 | Received 06 Nov 2020, Accepted 04 Oct 2021, Published online: 20 Dec 2021
 

ABSTRACT

In the present study, five Penicillium species, namely, P. italicum, P. expansum, P. simplicissimum, P. oxalicum, and P. citrinum, were identified using ITS (internal transcribed spacer) and β-tubulin markers and screened for their in vitro antagonistic potential against a soil-borne fungal pathogen, Macrophomina phaseolina, in a dual-culture plate assay. Among all the tested strains, P. italicum showed the highest antagonistic potential against M. phaseolina by reducing its growth up to 57% over control, followed by P. citrinum (42%), P. simplicissimum (21%), P. expansum (11%), and P. oxalicum (9%). In order to find out the mechanism of action of P. italicum, genomic DNA of M. phaseolina was exposed to P. italicum secondary metabolites. The findings showed that these metabolites completely degraded the fungal DNA after the 48-h incubation period. To further explore the antifungal mechanism of action of P. italicum, chloroform and ethyl acetate fractions of its metabolites were subjected to gas chromatography–mass spectrometry (GC-MS) analysis. The major compounds identified in these fractions were 9,12-octadecadienoic acid (Z,Z)- (25.19%), decane (19.72%), dodecane (18.05%), benzene, nitro- (14.62%), benzene, 1,3,5-trimethyl (14.37%), benzene, 1,4-diethyl (11.62%), 1,2-benzenedicarboxylic acid, mono(2-ethylhexyl) ester (9.02%), and 1-nonadecene (8.99%), which could be responsible for control of M. phaseolina growth.

DISCLOSURE STATEMENT

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.